Skip navigation

The Premiere Programme for Critical Insights into Evolving HCP Spend Disclosure Requirements and Data Protection Laws

April 2-3, 2019
  • Amsterdam, The Netherlands

CBI’s 9th Annual Global Transparency Reporting Congress provides up-to-date information on regulations and trends in reporting and managing transparency of payments to healthcare providers by bio/pharmaceutical and medical device firms. This conference will offer differing insights for how to achieve a globally compliant culture across the organisation, as well as transform the ethics of the organisation.

TIMELY CONTENT TO STAY UP-TO-DATE:

  • Leverage transparency data analytics to improve compliance monitoring
  • Establish a comprehensive and regulatory framework to successfully manage all HCP interactions
  • Learn best practices on how to gain consent and achieve accuracy of data
  • Understand GDPR operations since the effective date – May 25th, 2018
  • Evaluate the media perception on disclosure of data
  • Determine the best practices in tracking spend data and improving accuracy of data collection
  • Address how to effectively manage cross-border engagements
  • Gain an understanding of the latest developments in transparency reporting around the world (Asia Pacific, Latin America, Europe, Australia, Canada)

Previous Attendee Acclaim:

Interesting topics and opinions. Good opportunity
to network and share best practices.

–Disclosure Manager, Bayer Plc.

This is an interesting opportunity to share best practices and to feel that we are not the
only ones to struggle in our company.

–Compliance Transparency Manager, GE Healthcare

Very interesting overview of different approaches
and interpretations. Very educational.

–Supplier Evaluation & HCP Transparency Manager, Lundbeck

9th Annual Global Transparency Reporting Congress

The Premiere Programme for Critical Insights into Evolving HCP Spend Disclosure Requirements and Data Protection Laws

CBI’s 9th Annual Global Transparency Reporting Congress provides up-to-date information on regulations and trends in reporting and managing transparency of payments to healthcare providers by bio/pharmaceutical and medical device firms. This conference will offer differing insights for how to achieve a globally compliant culture across the organisation, as well as transform the ethics of the organisation.

TIMELY CONTENT TO STAY UP-TO-DATE:

  • Leverage transparency data analytics to improve compliance monitoring
  • Establish a comprehensive and regulatory framework to successfully manage all HCP interactions
  • Learn best practices on how to gain consent and achieve accuracy of data
  • Understand GDPR operations since the effective date – May 25th, 2018
  • Evaluate the media perception on disclosure of data
  • Determine the best practices in tracking spend data and improving accuracy of data collection
  • Address how to effectively manage cross-border engagements
  • Gain an understanding of the latest developments in transparency reporting around the world (Asia Pacific, Latin America, Europe, Australia, Canada)

Previous Attendee Acclaim:

Interesting topics and opinions. Good opportunity
to network and share best practices.

–Disclosure Manager, Bayer Plc.

This is an interesting opportunity to share best practices and to feel that we are not the
only ones to struggle in our company.

–Compliance Transparency Manager, GE Healthcare

Very interesting overview of different approaches
and interpretations. Very educational.

–Supplier Evaluation & HCP Transparency Manager, Lundbeck